MPM BioImpact’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
Other funds holding VIR
MPM BioImpact's VIR Position: Q3 2026 in Review
MPM BioImpact opened a new position in Vir Biotechnology (VIR) in Q3 2026: 2,809,711 shares worth $31.4M. The stake represents 2.33% of the portfolio and ranks #18 among its holdings.
263 funds tracked by Wall St. Rank hold VIR as of Q3 2026.
- MPM BioImpact held 2,809,711 shares of Vir Biotechnology worth $31.4M as of Q3 2026.
- Vir Biotechnology was a new MPM BioImpact position in Q3 2026.
- Vir Biotechnology made up 2.33% of MPM BioImpact's portfolio in Q3 2026, its #18 holding.
- 263 funds tracked by Wall St. Rank held Vir Biotechnology as of Q3 2026.
Based on MPM BioImpact's 13F filing for Q3 2026, filed 16 Nov 2026.